
zzso B zzso receive signals from zzso zzso zzso zzso that are triggered by binding of the zzso to an external zzso zzso signaling through the zzso provides growth and signals to chronic zzso leukemia zzso cells, and plays an important role in the zzso and progression of the zzso zzso engagement of zzso is followed by zzso recruitment and zzso of zzso zzso including zzso zzso zzso zzso zzso zzso zzso zzso and zzso zzso zzso zzso of signaling pathways downstream of the zzso zzso disruption of zzso zzso cell migration and cell zzso zzso signal zzso zzso represent a promising new strategy for targeted zzso zzso A number of therapeutic agents have recently been developed with significant activity in zzso The compounds that are currently investigated in patients with zzso include zzso zzso of zzso zzso of zzso and zzso zzso zzso specific zzso of the zzso zzso zzso The clinical activity of zzso zzso and zzso in patients with zzso is associated with marked zzso due to release of tumor cells from the zzso zzso into the peripheral zzso Further studies are ongoing with single agents and their combinations with other targeted and conventional zzso This article will review the zzso rationale of zzso signaling zzso in the treatment of zzso and the clinical evidence supporting the use of these agents in zzso zzso 

